Auriga Downgrades MedAssets (MDAS) to Hold
More News related to MDAS
- Thomas Weisel Initiates Coverage on MedAssets (MDAS) with an Overweight
- Samuel K. Skinner Joins MedAssets' Board of Directors
- MedAssets 2009 Technology and Innovation Forum Advances Progress in Healthcare Supplier Marketplace
- MedAssets (MDAS) Reports non-GAAP Q3 EPS of $0.22
- MedAssets Reports Third Quarter and Nine-Month 2009 Financial Results
More News related to Downgrades
- After-Hours Movers 11/24: QADI, JCG, ASYS Higher; DRAM, CWTR Lower
- Trading Radar for 11/25: Deere & Co. (DE), Tiffany & Co. (TIF), Conn's (CONN) Report
- Afternoon ETF Check: SMH Up; XLF, TAN, EWJ Down
- Unusual 11 Mid-Day Movers 11/24: IWA, DRAM, ABG, TIXC Higher; WH, WMG, ABIO, NYNY Lower
- Notable Analyst Rating Changes 11/24: ABG, PRU, RS, AYI, AMLN, TLAB Upgraded; DELL, CIEN, UNP, ALV Downgraded
Auriga downgrades MedAssets (Nasdaq: MDAS) from Buy to Hold. Price target increased by $1 to $25.
To see more analyst ratings on MDAS Click Here.
MedAssets, Inc. provides technology enabled products and services for hospitals, health systems, and ancillary healthcare providers in the United States.
Related Categories
DowngradesStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
